Oral administration of iopentol (Imagopaque® 300 mg I/ml) compared with amidotrizoate (Peritrast® 300 mg I/ml), both diluted to 2 % (v/v), in imaging of the gastrointestinal tract in abdominal contrast enhanced CT A clinical trial assessing patient tolerance, distribution of contrast medium and Hounsfield unit measurements